Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02715934 · ClinicalTrials.gov registry record · NA

Glucose to Goal: A Model to Support Diabetes Management in Primary Care

A NA study of Diabetes Mellitus, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
4,994
Enrollment target
1
Study location

NCT02715934 is a NA study of Diabetes Mellitus that has completed, run by University of Pittsburgh. The registered enrollment target is 4,994 participants, above the 1,843-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (171% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02715934, a NA study of Diabetes Mellitus, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
4,994 participants
Enrollment target
1
Study location

Study Summary

Diabetes education is a very important part of diabetes care. Most people with diabetes receive care in primary care practices where diabetes education is not always available. This project tests a model designed to improve access to diabetes education services.

Conditions Studied

Interventions

  • OTHER Usual Care
  • OTHER Glucose to Goal

Study Locations (1)

Pennsylvania

  • UPMC Community Medicine, Inc. - Pittsburgh

Trial Details

FieldValue
Enrollment Target 4,994 participants
Start Date 2016-04
Est. Completion 2017-12-31
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT02715934

The ClinicalTrials.gov registry entry for NCT02715934 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4,994 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,843-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (171% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT02715934 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02715934 about?

NCT02715934 is a clinical study titled "Glucose to Goal: A Model to Support Diabetes Management in Primary Care". Diabetes education is a very important part of diabetes care. Most people with diabetes receive care in primary care practices where diabetes education is not always available. This project tests a model designed to improve access to diabetes education services.

What is the current status of trial NCT02715934?

This trial is currently completed. It is a NA study. The enrollment target is 4,994 participants. The study started on 2016-04. Estimated completion is 2017-12-31.

What conditions does trial NCT02715934 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT02715934?

The interventions under investigation include: Usual Care (OTHER), Glucose to Goal (OTHER).

Who is sponsoring clinical trial NCT02715934?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02715934 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.